About New Approaches to Neuroblastoma Treatment (NANT)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at New Approaches to Neuroblastoma Treatment (NANT)
During the past decade, New Approaches to Neuroblastoma Treatment (NANT) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at New Approaches to Neuroblastoma Treatment (NANT)
According to Clinical.Site data, the most researched conditions in "New Approaches to Neuroblastoma Treatment (NANT)" are
"Recurrent Neuroblastoma" (2 trials) and "Disseminated Neuroblastoma" (1 trials). Many other conditions were trialed in "New Approaches to Neuroblastoma Treatment (NANT)" in a lesser frequency.
Clinical Trials Intervention Types at New Approaches to Neuroblastoma Treatment (NANT)
Most popular intervention types in "New Approaches to Neuroblastoma Treatment (NANT)" are "Biological" (2 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "aldesleukin" (1 trials), "autologous bone marrow transplantation" (1 trials), "filgrastim" (1 trials), "laboratory biomarker analysis" (1 trials) and "peripheral blood stem cell transplantation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at New Approaches to Neuroblastoma Treatment (NANT)
The vast majority of trials in "New Approaches to Neuroblastoma Treatment (NANT)" are
2 trials for "All" genders.
Clinical Trials Status at New Approaches to Neuroblastoma Treatment (NANT)
Currently, there are NaN active trials in "New Approaches to Neuroblastoma Treatment (NANT)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in New Approaches to Neuroblastoma Treatment (NANT),
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in New Approaches to Neuroblastoma Treatment (NANT), 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".